Exelixis (EXEL) Income towards Parent Company (2010 - 2026)

Exelixis' (EXEL) quarterly Income towards Parent Company came in at $210.5 million in Q2 2026, up 31.86% year-on-year from $159.6 million in Q2 2025, and down 13.93% quarter-over-quarter from $244.5 million in Q1 2026.

Exelixis (EXEL) Income towards Parent Company (2010 - 2026) Analysis & Trends

Exelixis' Income towards Parent Company history runs 17 years deep, the most recent figure standing at $210.5 million for Q2 2026.

  • On a quarterly basis, Income towards Parent Company rose 31.86% year-over-year to $210.5 million in Q2 2026; TTM through Apr 2026 was $833.4 million, a 29.5% increase from a year earlier, with the FY2026 full-year figure at $782.6 million, up 50.13% from the prior year.
  • Income towards Parent Company slipped to $210.5 million in Q2 2026 per EXEL's latest filing, from $244.5 million in the prior quarter.
  • Across five years, Income towards Parent Company topped out at $244.5 million in Q1 2026 and bottomed at -$30.2 million in Q4 2022.
  • The 5-year median for Income towards Parent Company is $85.5 million (2023), against an average of $112.0 million.
  • Across the five-year window, Income towards Parent Company plunged 131.71% in 2022 and soared 11232.66% in 2024, its largest moves.
  • Year by year, Income towards Parent Company stood at -$30.2 million in 2022, then surged by 383.43% to $85.5 million in 2023, then jumped by 37.95% to $118.0 million in 2024, then jumped by 64.09% to $193.6 million in 2025, then increased by 8.72% to $210.5 million in 2026.
  • Per Business Quant, the three latest EXEL Income towards Parent Company figures stand at $210.5 million (Q2 2026), $244.5 million (Q1 2026), and $193.6 million (Q4 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn
7 Belite Bio 62.72 Bn 62.72 Bn -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn
9 Revolution Medicines 37.35 Bn 37.35 Bn -
10 Exelixis 14.44 Bn 13.66 Bn 590.86 Mn

Historic Data

Download Data
DateValue
Apr 3, 2026 210.47 Mn
Jan 2, 2026 244.53 Mn
Oct 3, 2025 193.58 Mn
Jul 4, 2025 184.85 Mn
Apr 4, 2025 159.62 Mn
Jan 3, 2025 139.86 Mn
Sep 27, 2024 117.97 Mn
Jun 28, 2024 226.12 Mn
Mar 29, 2024 37.32 Mn
Dec 29, 2023 85.52 Mn
Sep 29, 2023 1.04 Mn
Jun 30, 2023 81.18 Mn
Mar 31, 2023 40.03 Mn
Dec 30, 2022 -30.17 Mn
Sep 30, 2022 73.21 Mn
Jul 1, 2022 70.67 Mn
Apr 1, 2022 68.57 Mn
Dec 31, 2021 95.17 Mn
Oct 1, 2021 38.20 Mn
Jul 2, 2021 96.09 Mn